Key Insights

Highlights

Success Rate

84% trial completion

Published Results

32 trials with published results (9%)

Research Maturity

175 completed trials (51% of total)

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

9.9%

34 terminated out of 345 trials

Success Rate

83.7%

-2.8% vs benchmark

Late-Stage Pipeline

10%

33 trials in Phase 3/4

Results Transparency

18%

32 of 175 completed with results

Key Signals

32 with results84% success34 terminated

Data Visualizations

Phase Distribution

168Total
Not Applicable (60)
Early P 1 (2)
P 1 (20)
P 2 (53)
P 3 (24)
P 4 (9)

Trial Status

Completed175
Unknown89
Terminated34
Withdrawn27
Recruiting13
Active Not Recruiting3

Trial Success Rate

83.7%

Benchmark: 86.5%

Based on 175 completed trials

Clinical Trials (345)

Showing 20 of 20 trials
NCT04447833Phase 1Completed

Mesenchymal Stromal Cell Therapy For The Treatment Of Acute Respiratory Distress Syndrome

NCT04910269Phase 3RecruitingPrimary

Outpatient Treatment With Anti-Coronavirus Immunoglobulin

NCT04367545Not ApplicableCompletedPrimary

Development of a Molecular Diagnostic Strategy for SARS-CoV2 Based on Saliva in the Context of the COVID-19 Pandemic

NCT06821139Completed

Cohort Study of Intraoperative Lung Protective Ventilation Trends in a Large Canadian Health Authority

NCT04382131Not ApplicableTerminated

Hypertonic Saline Nasal Irrigation and Gargling in Suspected or Confirmed COVID-19 (ELVIS COVID-19)

NCT04407143Completed

Study of the Immunity of Patients With Lung Cancer and COVID-19 Infection

NCT04394390CompletedPrimary

Vitamin D Levels in SARS-CoV-2: Do Current Adequacy Thresholds Reflect Clinical Risk? Insights From a Large Turkish Cohort

NCT04395599Not ApplicableCompleted

Risk of Air Contamination During Visceral Surgery in COVID19 Patients

NCT04411602Phase 1Withdrawn

Intermediate IND Severe Illness COVID-19 CP

NCT04425616Not ApplicableCompleted

SafeFit Trial: Virtual Clinics to Deliver Universal Interventions in People With Cancer

NCT03590327Not ApplicableCompleted

Transcranial Magnetic Stimulation for Apathy in Mild Cognitive Impairment

NCT03452774Recruiting

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

NCT07221097Recruiting

Prospective Clinical Evaluation of the BioFire Emerging Coronavirus Panel for the Detection of COVID-19 and Other Coronaviruses

NCT06744660Not ApplicableRecruiting

Clinical Validation of the Aptitude Medical Systems Metrix COVID-19 Test

NCT07196306Phase 2WithdrawnPrimary

Subcutaneous Sarilumab vs Placebo in Hospitalized Patients With Respiratory Distress Caused by COVID 19

NCT06652451CompletedPrimary

Covid-19 Data Analyses in Brazil

NCT04385160Completed

Myeloproliferative Neoplasms (MPN) and COVID-19

NCT04356833Phase 2CompletedPrimary

Nebulised Rt-PA for ARDS Due to COVID-19

NCT04568148Active Not Recruiting

COVID-19 Biorepository

NCT04402957Phase 2CompletedPrimary

LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19)

Scroll to load more

Research Network

Activity Timeline